Chris Mancill
Senior Vice President, Market Access
Responsibilities
Chris leads the US Market Access organization and is responsible for ensuring appropriate patient access to AstraZeneca’s medicines across the Biopharmaceuticals Business Unit (BBU) and the Oncology Business Unit (OBU). In this role, he is a member of the US Leadership Teams for both the BBU and the OBU.
Prior Experience
Chris brings over 30 years of experience in healthcare and market access at the US and global levels. Most recently, he served as the Senior Vice President for Global Market Access, Pricing, and Value Demonstration at Bristol Myers Squibb and earlier served there as the Senior Vice President for US Market Access and Pricing. Before BMS, he held leadership roles in market access, public policy, and government affairs at MorphoSys AG (acquired by Novartis AG), Merck KGaA, and Amgen. In his career, Chris has served twice on the Board of the National Pharmaceutical Council.
Education
- Master of Arts, University of Virginia, Charlottesville, VA
- Bachelor of Arts, Christopher Newport University, Newport News, VA
Affiliations
- Executive Advisory Board, ACCESS Forum
- Member, Healthcare Financial Management Association
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.
Use a maximum of two downloads here